InvestorsHub Logo

PJ007

01/07/21 8:03 PM

#339037 RE: georgejjl #339035

Great find George!!!!! Great days are coming!!!!

DaubersUP

01/07/21 8:20 PM

#339038 RE: georgejjl #339035

Interesting. Not too long ago at all.

loanranger

01/07/21 8:40 PM

#339041 RE: georgejjl #339035

Second time around for this one. It's a patent application, NOT a granted patent.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160124367

LilyGDog

01/07/21 9:30 PM

#339045 RE: georgejjl #339035

Nice find George!

Go Leo and IPIX!

Very interesting fairly recent patent

United States Patent Application 20200368232
Kind Code A1
MENON; Krishna November 26, 2020
Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract

Abstract
The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.

Inventors: MENON; Krishna; (Beverly, MA)
Applicant:
Name City State Country Type

INNOVATION PHARMACEUTICALS INC.
Beverly
MA
US
Assignee: INNOVATION PHARMACEUTICALS INC.
BEVERLY
MA
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220200368232%22.PGNR.&OS=DN/20200368232&RS=DN/20200368232

Good luck and GOD bless

Lemoncat

01/07/21 9:42 PM

#339047 RE: georgejjl #339035

Does Leo know about this?

Why would a guy who doesn't work for the company patent our drug? Or is it a competing drug?

Go IPIX!

kfcyahoo

01/07/21 10:18 PM

#339052 RE: georgejjl #339035

"Very interesting fairly recent patent

United States Patent Application 20200368232
Kind Code A1
MENON; Krishna November 26, 2020
Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract"

Paragraph of 10Q dated Feb 2020, article 8, paragraph #3: "The Company determined that the operating lease right-of-use asset is fully impaired on September 30, 2019 because of the Company’s current lack of working capital (see Note 2. Going Concern and Liquidity to the condensed consolidated financial statements) resulting in its limited usage of the leased office. The Company has been unable to enter into a sub-lease agreement for this leased office on September 30, 2019.]As such, the Company recognized an impairment loss of approximately $643,000, after recording amortization of the right-of-use asset for July, August, and September 2019 totaling approximately $27,000, resulting in a carrying value of $0 since September 30, 2019. The Company vacated the leased office space as of December 31, 2019, and in January 2020 the Company initiated a lawsuit against the leasor relating to an automatic extension of the lease for the office space and related matters (see Note 15. Subsequent Events to the condensed consolidated financial statements)."

Sloppy, as usual.

georgejjl

01/08/21 6:41 PM

#339177 RE: georgejjl #339035

This application is, a continuation of U.S. Ser. No. 15/042.973 filed Feb. 12, 2016, which claims the benefit of U.S. Provisional Application 62/118,950 filed Feb. 70, 2015, and incorporates the same by reference.

[0002] The present invention relates to the use of host defense protein (HDP) mimetics, including brilacidin (PMX-30063) and delparantag (PMX-60056), and the pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof in preventing and treating inflammatory diseases of the gastrointestinal tract.


United States Patent Application 20200368232
Kind Code A1
MENON; Krishna November 26, 2020
Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract

Abstract
The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.

Inventors: MENON; Krishna; (Beverly, MA)
Applicant:
Name City State Country Type

INNOVATION PHARMACEUTICALS INC.
Beverly
MA
US
Assignee: INNOVATION PHARMACEUTICALS INC.
BEVERLY
MA
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220200368232%22.PGNR.&OS=DN/20200368232&RS=DN/20200368232

Good luck and GOD bless,